KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Accumulated Expenses (2016 - 2026)

Lam Research has reported Accumulated Expenses over the past 17 years, most recently at $2.1 billion for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 3.78% year-over-year to $2.1 billion; the TTM value through Mar 2026 reached $2.1 billion, up 3.78%, while the annual FY2025 figure was $2.4 billion, 32.88% up from the prior year.
  • Accumulated Expenses for Q1 2026 was $2.1 billion at Lam Research, down from $2.3 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $2.4 billion in Q3 2025 and troughed at $1.6 billion in Q1 2022.
  • A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: fell 10.38% in 2024 and later surged 32.88% in 2025.
  • Year by year, Accumulated Expenses stood at $2.1 billion in 2022, then dropped by 4.47% to $2.0 billion in 2023, then rose by 6.08% to $2.1 billion in 2024, then increased by 8.18% to $2.3 billion in 2025, then decreased by 8.47% to $2.1 billion in 2026.
  • Business Quant data shows Accumulated Expenses for LRCX at $2.1 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.4 billion in Q3 2025.